THE newest and most advanced cancer treatment in the world is now available to patients of Mary Mediatrix Medical Center in ...
Blue Shield of California is the latest major insurer to scale back coverage for proton beam therapy for early stage prostate cancer, according to a Wall Street Journal report. In letters sent this ...
Futuristic 3D cubes showing DNA base pairs and a double helix. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive ...
A Beam Therapeutics gene-editing therapy designed to fix a mutation at the root of a rare liver protein deficiency now has early signs of efficacy along with safety data that ease some concerns about ...
Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...
Beam Therapeutics’ experimental gene-editing therapy for sickle cell disease now has its first cut of patient data showing signs of treating the rare blood disorder in a way that could differentiate ...
In the article that accompanies this editorial, Howard et al 1 provide a state of the union summary regarding the status of proton therapy in the United States. Proton therapy is a rapidly growing ...
The plans for a proton beam therapy center include demolishing an existing building in Durham.
Inquirer Business on MSN
Mary Mediatrix in Batangas launches proton beam therapy for cancer
MANILA, Philippines — Medical patients in Southern Luzon may now access what Mary Mediatrix Medical Center in Lipa City, Batangas, touts as “the most advanced cancer treatment in the world.” Realized ...
On Tuesday, Beam Therapeutics Inc. (NASDAQ:BEAM) announced that 35 patients have cleared screening and enrolled in the BEACON Phase 1/2 trial of BEAM-101, an investigational genetically modified cell ...
CAMBRIDGE, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (BEAM) (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Pediatric and adult oncology patients at Atrium Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results